|
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
RECRUITINGPhase 2Sponsored by Alveus Therapeutics, Inc.
Actively Recruiting
PhasePhase 2
SponsorAlveus Therapeutics, Inc.
Started2026-08-10
Est. completion2027-08-24
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
Locations20 sites
View on ClinicalTrials.gov →
NCT07837973
Summary
A study of ALV-100 to assess efficacy, safety and tolerability among participants with overweight or obesity who have previously achieved a body weight reduction of ≥10% while treated with incretin-based therapies.
Eligibility
Age: 18 Years – 75 YearsHealthy volunteers accepted
Key inclusion criteria 1. Adult male and female participants, aged ≥18 to ≤75 2. BMI ≥23 kg/m2 at screening. 3. Has been treated with incretin-based therapy for weight management at a stable dose for at least 3 continuous months prior to screening. 4. Tolerating incretin-based therapy at the discretion of the investigator 5. WL of at least 10% while on incretin-based therapy and with stable BW for at least 3 months prior to screening. 6. Willing to maintain their current general diet and physical activity regimen throughout the study. Key exclusion criteria 1. Lifetime history of Type 1 or Type 2 diabetes 2. Prior obesity treatment with surgery or a weight loss device. 3. Obesity caused by known endocrinologic disorders or by known congenital or acquired hypothalamic disease or monogenetic or syndromic forms of obesity. 4. Current or history of (within 3 months prior to screening) treatment with medications that may cause significant weight gain. 5. Family or personal history of MTC or MEN 2 6. Presence or history of malignant neoplasms within the past 5 years prior to screening
Conditions3
AdultsOverweight/ObesityWeight Loss
Interventions1
Locations20 sites
University of Alabama - Birmingham
DM Clinical Research
Profound Research
DM Clinical Research
Find trials near these locations
Weight Loss trials in OrlandoWeight Loss trials in New YorkWeight Loss trials in Oklahoma CityWeight Loss trials in NashvilleWeight Loss trials in San AntonioAll trials in AlabamaAll trials in ArizonaAll trials in CaliforniaAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in LouisianaAll trials in MichiganAll trials in New YorkAll trials in North CarolinaAll trials in OklahomaAll trials in TennesseeAll trials in TexasAll trials in Utah
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorAlveus Therapeutics, Inc.
Started2026-08-10
Est. completion2027-08-24
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
Locations20 sites
View on ClinicalTrials.gov →
NCT07837973